CluePoints Partners With ZS To Provide Best-In-Class RBQM Expertise And Technology, Increasing Clinical Trial Efficiency And Improving Patient Outcomes
CluePoints, the premier provider of Risk-Based Quality Management software for clinical trials, has partnered with ZS, a global professional services firm with technology and analytics expertise in biopharma, to offer innovative capabilities in portfolio-level performance oversight. The new partnership pairs a best-in-breed solutions company focused on study-level risk-based management with a pharmaceutical and biotech solutions provider with advanced […]
Introducing CluePoints’ Post-COVID Trial Assurance Solution
For well over a year now, the clinical research community has been hard at work to maintain progress in developing new treatments and therapies to improve, protect, extend, and save lives. For many sponsors and CROs, the pandemic has been the catalyst for reassessing pre-existing monitoring protocols to ensure that studies stay on track, particularly […]
Revealing The Bigger Picture Through Metadata & Building RBQM Standards Of The Future
Risk-Based Monitoring (RBM) is the future of clinical trials. Yet, despite significant progress in recent years, many practical challenges remain in making it fully effective. That’s why CluePoints is introducing a new, data-driven dashboard designed to help Sponsors and CROs benchmark projects—not only across protocols and portfolios, but also against industry standards through the CluePoints […]
CluePoints Sponsors RBQM Live, The Definitive Guide To RBQM For Experts And Beginners
Have you heard the news? CluePoints is sponsoring RBQM Live on behalf of the industry! The adoption of Risk-Based Quality Management (RBQM) is accelerating, and it’s more important than ever for the industry to come together and share expertise. Taking place on May 20-21, 2021, this two-day live virtual event is a definitive guide for anyone working […]
Centralized Monitoring: Effective Technology & Documented Evidence Are The Perfect Double Act
If it isn’t documented, it didn’t happen. This mindset has shaped the way clinical monitoring activities, both on-site and remote, are reported and standardized. But as centralized monitoring becomes the norm, how can Sponsors and CROs apply this philosophy to a model built on data-driven oversight? Frédéric Blais, PhD, Director of Central Monitoring at CluePoints, […]
CluePoints To Share COVID-Informed RBQM Best Practice At #SCOPE2021
It has never been more important for the clinical trial community to come together and share best practice – which is why CluePoints is delighted to be taking part in SCOPE 2021. The Summit for Clinical Operations Executives, which will be held online between 2nd and 4th March, 2021, is an opportunity to drive innovation across the […]
CluePoints’ Risk-Based Quality Management Platform Instrumental In Data Quality Oversight Of COVID-19 Trials
King of Prussia, PA – January 19, 2021: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that its Risk-Based Quality Management (RBQM) platform has been critical in supporting numerous Pharmaceutical companies and CROs to interrogate data in their global COVID-19 vaccine and antiviral antibody trials to ensure data quality […]
CluePoints Opens New APAC Office In Tokyo
King of Prussia, PA – December 8th, 2020: CluePoints, the premier provider of Central Statistical Monitoring, Risk-Based Quality Management and Data Quality Oversight Software for clinical trials, today announced further expansion in Japan with the opening of a new office in Tokyo. Dedicated to serving their Japanese clients, the new office builds on CluePoints’ presence in the region, […]
CluePoints Joins Forces With Global Growth Investor Summit Partners To Expand Market Leadership Position In Risk-Based Quality Management
LOUVAIN-LA-NEUVE, BELGIUM; KING OF PRUSSIA, PA; and LONDON, UK (September 1, 2020) – CluePoints S.A., a provider of Risk-Based Study Execution (RBx) and Data Quality Oversight software for clinical trials, today announced a minority investment from Summit Partners, a global growth equity investor with $21 billion in assets under management. Summit will support the company’s […]
Over 300 Clinical Studies Benefit From CluePoints’ COVID-19 Risk Management Support
Addressing COVID-19 Specific Regulatory Guidance and Ensuring Early Risk Detection King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced the success of its complimentary COVID-19 risk management package alongside comprehensive support for COVID-19 affected trials. Launched in April in the wake of COVID-19, […]
